Aiforia: Unlocking diagnostic value at Fimlab with Aiforia® Breast Cancer Suite
recent articles
From the Aiforia blog: In modern clinical pathology, adopting artificial intelligence (AI) is no longer just about algorithm accuracy. A key success factor is seamless workflow integration. Pathology departments manage high sample volumes...
From the Pathomation blog: Modern digital pathology software must go far beyond simple image viewing. Today’s solutions need to integrate seamlessly with laboratory systems, research platforms, AI pipelines, and web...
EIB provides €20 million venture debt financing to Finnish life-science company Aiforia, to further develop its AI powered platform used in digital tissue analysis. Supported under the European Commission’s InvestEU programme, the...
Albuquerque, NM, July 30, 2026 – Indica Labs today announces the launch of the ADC Target Scoring module for the HALO® image analysis platform, a powerful new functionality that supports the development of next-generation precision...
The latest from the Indica Labs Blog Automated biomarker scoring for breast cancer pathology just got smarter. The latest HALO Breast IHC AI release introduces new features designed to remove the remaining manual steps from...
Albuquerque, NM, July 28, 2026 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced new intelligent tissue classification capabilities for HALO Breast IHC AI, its AI-powered breast...
